Medical Device Vulnerability Management: A Practical Guide

TL;DR: Medical device vulnerability management is the process of finding, prioritizing, and fixing security flaws in connected medical equipment before attackers reach them. It's not the same as IT patching, because you can't always take a device offline and you can't fix a flaw you can't see. The strongest programs start at the firmware level, build a software bill of materials for what actually shipped, and prioritize by real exploitability instead of raw severity scores.

Medical devices are central to patient care, and they're increasingly connected and software-driven. That shift brought real gains in diagnostics, treatment, and clinical decision support. It also brought a new problem: a vulnerability in a connected device can lead to a data breach, a disrupted procedure, or direct harm to a patient.

This guide covers what medical device vulnerability management is, why these devices are so exposed, how it differs from standard IT security, how to prioritize and remediate, what FDA guidance requires, and where a software bill of materials fits in. One idea runs through all of it: you can't manage a vulnerability you never knew was there.

What is medical device vulnerability management?

Medical device vulnerability management is the process of finding, assessing, prioritizing, and fixing security flaws in connected medical devices to protect patient safety and data.

Vulnerabilities come from many places: software bugs, misconfigurations, design flaws, and outdated or third-party components carried inside the device. Any one of them can leave a connected device open to exploitation. Managing them well is what keeps a healthcare environment, and the patients in it, protected.

Medical devices are part of a wider category called the internet of medical things (IoMT), which includes patient monitors, imaging systems, infusion pumps, and wearable or implantable sensors. What sets these apart from ordinary connected hardware is the stakes. If a laptop is compromised, you lose data. If an infusion pump or cardiac monitor is compromised, you can lose a patient. That's why healthcare vulnerability management needs its own discipline, built on our broader work in medical device security.

Why are connected medical devices particularly vulnerable to cybersecurity threats?

Connected medical devices are especially vulnerable because they run long, patch slowly, and are built from third-party and open-source components that hide known flaws deep inside device firmware.

Three factors stack up. First, long service lives. A device can stay in clinical use for a decade or more, well past the point where its underlying software still gets updates. Second, slow or impossible patching, because you can't take a life-supporting device offline on a whim, and some implants can't be patched at all. Third, complex supply chains. Modern device software is largely assembled from third-party and open-source components, and a single reused library can carry vulnerabilities the manufacturer never wrote and the hospital never sees.

That third point is the one most programs miss. A device can look clean on paper while its firmware carries dozens or hundreds of known CVEs inside embedded components. One industry report co-written by Finite State with Health-ISAC and Securin flagged a 59% year-over-year jump in firmware vulnerabilities in medical devices. [verify before publishing: this figure is from the 2023 State of Cybersecurity for Medical Devices and Healthcare Systems report; confirm it's still the figure you want to cite or update to the latest edition.]

Why is medical device cybersecurity different from standard IT security?

Medical device cybersecurity differs from standard IT security because patient safety, real-time operation, and regulatory constraints often make it impossible to simply patch, reboot, or take a device offline.

In a normal IT environment, the answer to a vulnerability is usually "patch it," and if that means a reboot at 2 a.m., so be it. Medical devices don't give you that freedom. A patch may need manufacturer validation, regulatory review, and a maintenance window that doesn't disrupt care. Some devices can't be touched at all without risking their clinical function.

So the traditional playbook falls short. Standard tools also tend to rank vulnerabilities by raw severity score alone, which floods already-stretched biomedical and security teams with fixes that may never actually be exploited. Medical device vulnerability management has to account for clinical impact, device constraints, and real exploitability, not just a severity number. It's a tailored discipline, not a repurposed IT one.

Which medical device vulnerabilities should you prioritize first?

Prioritize vulnerabilities by combining three signals: how severe the flaw is, how likely it is to be exploited in the wild, and how badly exploitation would affect patient safety.

Ranking by severity score alone is where many programs go wrong. A high-severity flaw in a component that isn't reachable and isn't being exploited may matter far less than a medium-severity one that attackers are actively using. Public exploitability data helps you tell the difference, and reachability analysis tells you whether a flawed component is even exposed in how the device actually runs.

CISA is explicit that its Known Exploited Vulnerabilities catalog should feed your prioritization, not replace your own judgment. Layering that exploitation data on top of device-level reachability is how you cut the noise and fix what actually matters first.

What are the best practices for managing security vulnerabilities in connected medical equipment?

The best practices for medical device vulnerability management are: build a complete device inventory, analyze firmware to find hidden components, prioritize by real risk, coordinate across teams, and manage patching across the full lifecycle.

None of this works without the first step. You can't secure what you can't see, and an inventory built only from what devices report on the network is only as honest as the devices themselves. Here's what a strong program includes:

• Inventory and firmware analysis. Start with a full inventory of every connected device, then go a layer deeper and analyze the firmware to surface the embedded components a network scan can't see. This is the foundation of any real vulnerability management program for medical devices.
• Risk-based prioritization. Rank findings using severity, active-exploitation data, and clinical impact together, so limited resources go to the flaws that matter.
• Collaboration and communication. Effective response needs IT, biomedical engineering, and security working from the same information, with clear channels for acting on new threats.
• Patch management. Build a strategy for timely, validated patching that weighs the effect on device function and patient safety, and plan compensating controls for devices you can't patch.
• Full-lifecycle coverage. Manage security from design and development through deployment and decommissioning, not just at release.

For manufacturers, much of this hinges on knowing exactly what shipped, which is why binary and firmware analysis sits at the center of the program rather than the edge.

Should you use passive or active vulnerability scanning?

Use passive scanning for continuous, non-disruptive monitoring of sensitive clinical devices, and active scanning where you need deeper results and can safely tolerate the extra traffic.

Both have a place. The right mix depends on how fragile a given device is and how much detail you need. Many health system vulnerability management tools support both so you can match the method to the device.

Neither approach sees inside the firmware on its own. Network scanning tells you a device exists and how it behaves. It doesn't tell you which vulnerable components are compiled into the binary. That's the gap firmware analysis fills.

What role does a Software Bill of Materials (SBOM) play in medical device security?

A software bill of materials (SBOM) lists every software component inside a device, so teams can match those components against known vulnerabilities and track risk across the device's entire lifecycle.

Think of an SBOM as the ingredient label for a device's software. Without it, you're guessing at what's inside and reacting to disclosures blind. With it, the moment a new vulnerability lands in a common library, you can tell in minutes which devices are affected instead of scrambling for weeks.

This is where the best solutions for medical device vulnerability management separate from the rest. An SBOM inferred from a network scan or copied from a supplier's paperwork is only as good as its source. A ground-truth SBOM built by analyzing the firmware itself reflects what actually shipped, embedded and open-source components included. That's the system of record a defensible program runs on. For the mechanics, see how SBOMs streamline medical device security and how Finite State aligns with FDA requirements for medical device SBOMs.

What do FDA guidelines require for medical device vulnerability management?

FDA guidance requires manufacturers of connected "cyber devices" to provide an SBOM, monitor and address postmarket vulnerabilities, run coordinated disclosure, and deliver timely patches across the device lifecycle.

Two documents anchor the expectations. FDA Section 524B, added to the FD&C Act in 2023, makes an SBOM and a postmarket vulnerability management plan legal requirements for cyber devices. The FDA's Postmarket Management of Cybersecurity in Medical Devices guidance sets the risk-based framework for handling vulnerabilities after a device is on the market, treating cybersecurity as part of device safety across its whole life.

The practical takeaway: clearance is the start of your cybersecurity obligations, not the finish. Manufacturers are expected to keep monitoring components, assess how each new flaw affects safety and effectiveness, and patch or mitigate on a defensible timeline. For a fuller breakdown, see our guide to FDA cybersecurity regulations for medical devices, what the FDA's final guidance says about SBOMs, and how to put Section 524B into practice.

How do you build a medical device vulnerability management program?

Build a program by pairing full device visibility with firmware-level analysis, then wrap it in risk-based prioritization, cross-team collaboration, lifecycle patch management, and continuous reassessment.

Done well, a vulnerability management program for medical devices pays off in more than security. It builds patient confidence, supports compliance with FDA and healthcare regulations, reduces breach risk, and protects your reputation. The benefits are real, but they only follow if the foundation is right.

That foundation is visibility at two levels. Most programs stop at the network and inherit whatever blind spots the devices carry. The stronger approach adds firmware analysis and a ground-truth SBOM so prioritization, patching, and reporting all rest on what actually shipped. Security here isn't a one-time project. It's a continuous commitment that has to keep pace with new vulnerabilities and an evolving threat landscape.

The bottom line

Medical device vulnerability management is not standard IT patching, and it's not a task you finish. It's an ongoing practice of finding flaws, ranking them by real risk, and fixing or containing them across a device's whole life. What decides whether you're actually protected is depth: whether you can see every device, and whether you can see inside each one down to the firmware.

See only part of the picture and you leave patients more exposed than you realize. If you want to see how firmware-level transparency changes the way you manage medical device risk, request a demo or read our resource on protecting medical devices from cyber exploitation. For where the field is heading, see what's next for medical device cybersecurity.